Coronavirus LIVE Update: India's Cases Rise To ‭‭19,64,536; 40,699 Dead

Live Updates

  • 4 Aug 2020 1:38 PM GMT

    India's COVID-19 Testing Lower Than Other Countries: WHO Chief Scientist

    WHO's Chief Scientist Dr Soumya Swaminathan said India's COVID-19 testing rate is lower than countries like Germany, Taiwan, South Korea and Japan and added that fighting the coronavirus without adequate testing is like "fighting fire blindfolded", reports PTI. "Even the United States is testing a huge number of people. So we need to have some benchmark and every public health department needs to have benchmarks on what is the rate of testing per lakh or per million, what is the test positivity rate,” she said.


  • 4 Aug 2020 11:55 AM GMT

    More Males Dying Due To COVID-19

    From the 38,938 deaths in the country, males constitute 68 per cent of the deaths in the country. Half of the deaths from the country came from the age group of individuals who were 60 and older. 

  • 4 Aug 2020 11:48 AM GMT

    28 States/UTs Have Positivity Rate Lower Than 10%

    India's positivity rate has fallen from 11 per cent to 8.89 per cent in this week with 28 states reporting less than 10 per cent positive cases from the total number of tests being conducted in the respective states. 

  • 4 Aug 2020 11:38 AM GMT

    Two Indian Vaccines Completed Phase I Trials: ICMR Chief

    Vaccine candidates by Bharat Biotech and Zydus Cadilla have completed Phase I trials of their indigenious vaccines, informed Balrama Bhargava, Director General of the Indian Council of Medical Research said in a press conference. 

    Bharat Biotech's inactivated virus vaccine has completed trials at 11 sites while Zydus Cadilla's plasmid DNA vaccine has completed trials in 17 sites too. 

    Serum Institute of India's Oxford vaccine will start Phase III trials. 


  • 4 Aug 2020 10:38 AM GMT

    Sun Pharma Launches Favipiravir, Latest Entrant To Produce Drug

    Sun Pharma launched its Favipiravir variant at 35 Rs per tablet making it the latest entrant to produce this anti-viral drug which is originally produced by Japan's Fujifilm Corporation. Glenmark, Cipla, Hetero, Jenburkt, Biophore are the other producers of favipiravir in the country. 

  • 4 Aug 2020 9:34 AM GMT

    Covaxin Trial At AIIMS: 20 Per Cent Participants Ineligible

    Over 20% of the participants who were screened for Bharat Biotech's Covaxin trials at AIIMS, Delhi cannot be administered the vaccine as they have already developed antibodies for COVID-19, reported The Indian Express.

    From the 3500 who applied for the trials, the apex hospital screened 80 participants, but only 16 have been recruited for the trial so far. Only one person has been administered the vaccine who has not developed any discomfort in a week after administration. In the screening, 1 in 5 had developed antibodies while a few others had other health issues which made them unfit for the trial. AIIMS has to recruit over 100 participants for the trial. 

  • 4 Aug 2020 9:04 AM GMT

    Philippines Reimposes Lockdown In Capital

    With cases surging in the country, Philippines is reimposing a lockdown for two weeks in Manila and its surrounding provinces. The country currently has over 1,06,000 cases with 2100 deaths. 

  • 4 Aug 2020 8:21 AM GMT

    India Reports Highest New Cases For The Second Day In A Row

    With 52,050 new cases, India has reported the highest number of new cases across the world for the second straight day. The United States of America reported 47,756 new cases according to the data compiled by the CDC while Brazil reported 16,641 cases in the last 24 hours. 

  • 4 Aug 2020 7:54 AM GMT

    Delhi To Extend Secound Round Of Serological Survey

    Delhi Health Minister Satyendar Jain has stated that the second round of its serological survey which began on August 1 will be extended by two days to August 6 as the government intends to collect 15,000 samples this time around. 

    In the first round, the sero-survey found that 23 per cent of the 21,837 samples had developed antibodies against COVID-19. 

  • 4 Aug 2020 6:44 AM GMT

    UN Warns Of 'Generational Catastrophe' Due To COVID-19 Enforced School Closures

    The United Nations has said that the COVID-19 pandemic will lead to a generational catastrophe following the disruption of education across the world, reports PTI. The UN's policy brief on education stated that the pandemic has affected nearly 1.6 billion students while an additional 23.8 million children and youth could drop out or not have access to school next year due to the pandemic’s economic impact. While launching the UN's policy brief on education UN Secretary General Antonio Guterres said, "Now we face a generational catastrophe that could waste untold human potential, undermine decades of progress, and exacerbate entrenched inequalities. The knock-on effects on child nutrition, child marriage and gender equality, among others, are deeply concerning."

Show Full Article
Next Story